Our results provide a new notion that OTUB2 is an immune regulator that targets and inhibits PD-L1 degradation, consequently leading to the promotion of T-lymphocyte-mediated antitumor immunity and suppression of tumor growth. The gene discussed is OTUB2; the disease is neoplasm.